scholarly journals PCN43 COST COMPARISON OF ERLOTINIB VERSUS PEMETREXED FOR THE FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN ITALY

2010 ◽  
Vol 13 (7) ◽  
pp. A259 ◽  
Author(s):  
S Ravera ◽  
S Walzer ◽  
J Ray
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Maintenance Treatment ◽  
Locally Advanced ◽  
Small Cell ◽  
Cost Comparison ◽  
Small Cell Lung ◽  
First Line

A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer

Lung Cancer ◽  
2012 ◽  
Vol 76 (3) ◽  
pp. 465-471 ◽  
Author(s):  
Mark J.C. Nuijten ◽  
Javier de Castro Carpeño ◽  
Christos Chouaid ◽  
Alain Vergnenègre ◽  
Francesco Grossi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Maintenance Treatment ◽  
Locally Advanced ◽  
Small Cell ◽  
Cost Comparison ◽  
Small Cell Lung ◽  
First Line

Gemcitabine-Induced Severe Peripheral Edema in a Patient With Lung Cancer

2012 ◽  
Vol 25 (3) ◽  
pp. 393-395 ◽  
Author(s):  
Stamatis Katsenos ◽  
Melita Nikolopoulou
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Locally Advanced ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Liver Transaminase ◽  
Peripheral Edema ◽  
Significant Toxicity

Gemcitabine, alone or in combination with a platinum-based agent, is indicated for the first-line treatment of patients with locally advanced or metastatic non–small-cell lung cancer. It is generally a well-tolerated drug. Despite its lack of significant toxicity, the most commonly reported side effects include myelosuppression, gastrointestinal disturbances (eg, nausea and vomiting), influenza-like symptoms, skin rash with pruritus, and elevation of liver transaminase enzymes. Peripheral edema has rarely been described as an adverse effect. Herein, we report a patient with advanced non–small-cell lung cancer who experienced severe peripheral edema after gemcitabine administration. Immediate gemcitabine discontinuation and the administration of diuretics resulted in definite regression of peripheral edema.

Sign in / Sign up

Export Citation Format

Share Document